Home / drugs / Glyxambi (empagliflozin and linagliptin)

Glyxambi (empagliflozin and linagliptin)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

July 2016

WARNINGS AND PRECAUTIONS

Ketoacidosis (addition of the following sentence in first paragraph)

Fatal cases listed

About Ajay C

Check Also

Recovery is a Process: Learn Ways to Cope After Rehabilitation

Addiction is a relapsing disease and thus recovery from it is a long-term process.  There …